This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Creativity depression: Difference between revisions
Jump to navigation
Jump to search
>Graham References: Antipsychotics def do through dopamine. GABAergics commonly causing this effect is tenuous; it both reduces any inhibiting factor towards creative output and increases thought disorganization. https://doi.org/10.1002/j.2162-6057.1999.tb01036.x |
>Graham m Ref: SSRI's can induce this effect |
||
| Line 4: | Line 4: | ||
Although creative subjects paradoxically more often have a history of depression than the average, their creative work is not done during their depressions, but in rebound periods of increased energy between depressions.<ref name="Flaherty2005"/><ref>Jamison, K. R. (1989). Mood disorders and patterns of creativity in British writers and artists. Psychiatry, 52(2), 125-134. https://www.ncbi.nlm.nih.gov/pubmed/2734415/</ref> | Although creative subjects paradoxically more often have a history of depression than the average, their creative work is not done during their depressions, but in rebound periods of increased energy between depressions.<ref name="Flaherty2005"/><ref>Jamison, K. R. (1989). Mood disorders and patterns of creativity in British writers and artists. Psychiatry, 52(2), 125-134. https://www.ncbi.nlm.nih.gov/pubmed/2734415/</ref> | ||
Creativity suppression is often accompanied by other coinciding effects such as [[depression]],<ref>von Hecker, U., & Meiser, T. (2005). Defocused attention in depressed mood: evidence from source monitoring. Emotion, 5(4), 456. https://doi.org/10.1037/1528-3542.5.4.456</ref> [[anxiety]], and [[emotion suppression]] in a manner which further decreases the person's creative abilities.<ref name="Flaherty2005"/> It is most commonly induced under the influence of [[dosage#common|moderate]] [[dosage|dosages]] of [[antipsychotics|antipsychotics]].<ref name="Flaherty2005"/><ref>Moncrieff, J., Cohen, D., & Mason, J. P. (2009). The subjective experience of taking antipsychotic medication: a content analysis of Internet data. Acta Psychiatrica Scandinavica, 120(2), 102-111. https://doi.org/10.1111/j.1600-0447.2009.01356.x</ref><ref name="Szmulewicz2016">Szmulewicz, A., Samamé, C., Caravotta, P., Martino, D. J., Igoa, A., Hidalgo-Mazzei, D., ... & Strejilevich, S. A. (2016). Behavioral and emotional adverse events of drugs frequently used in the treatment of bipolar disorders: clinical and theoretical implications. International journal of bipolar disorders, 4(1), 6. https://dx.doi.org/10.1186%2Fs40345-016-0047-3</ref> However, it can also occur | Creativity suppression is often accompanied by other coinciding effects such as [[depression]],<ref>von Hecker, U., & Meiser, T. (2005). Defocused attention in depressed mood: evidence from source monitoring. Emotion, 5(4), 456. https://doi.org/10.1037/1528-3542.5.4.456</ref> [[anxiety]], and [[emotion suppression]] in a manner which further decreases the person's creative abilities.<ref name="Flaherty2005"/> It is most commonly induced under the influence of [[dosage#common|moderate]] [[dosage|dosages]] of [[antipsychotics|antipsychotics]].<ref name="Flaherty2005"/><ref>Moncrieff, J., Cohen, D., & Mason, J. P. (2009). The subjective experience of taking antipsychotic medication: a content analysis of Internet data. Acta Psychiatrica Scandinavica, 120(2), 102-111. https://doi.org/10.1111/j.1600-0447.2009.01356.x</ref><ref name="Szmulewicz2016">Szmulewicz, A., Samamé, C., Caravotta, P., Martino, D. J., Igoa, A., Hidalgo-Mazzei, D., ... & Strejilevich, S. A. (2016). Behavioral and emotional adverse events of drugs frequently used in the treatment of bipolar disorders: clinical and theoretical implications. International journal of bipolar disorders, 4(1), 6. https://dx.doi.org/10.1186%2Fs40345-016-0047-3</ref> However, it can also occur due to SSRI's<ref>Bolling, M. Y., & Kohlenberg, R. J. (2004). Reasons for quitting serotonin reuptake inhibitor therapy: paradoxical psychological side effects and patient satisfaction. Psychotherapy and psychosomatics, 73(6), 380-385. https://doi.org/10.1159/000080392</ref> and during the [[withdrawal]] symptoms of any dopaminergic compound.<ref name="Szmulewicz2016"/></onlyinclude> | ||
===Psychoactive substances=== | ===Psychoactive substances=== | ||
Compounds within our [[psychoactive substance index]] which may cause this effect include: | Compounds within our [[psychoactive substance index]] which may cause this effect include: | ||
Revision as of 21:52, 21 August 2018
Creativity suppression is a decrease in both a person's motivation and capabilities when performing tasks that involve producing artistic output or novel problem-solving.[1] This effect may be particularly frustrating to deal with for artists of any sort as it will induce a temporary creative block.
Although creative subjects paradoxically more often have a history of depression than the average, their creative work is not done during their depressions, but in rebound periods of increased energy between depressions.[1][2]
Creativity suppression is often accompanied by other coinciding effects such as depression,[3] anxiety, and emotion suppression in a manner which further decreases the person's creative abilities.[1] It is most commonly induced under the influence of moderate dosages of antipsychotics.[1][4][5] However, it can also occur due to SSRI's[6] and during the withdrawal symptoms of any dopaminergic compound.[5]
Psychoactive substances
Compounds within our psychoactive substance index which may cause this effect include:
See also
External links
References
- ↑ 1.0 1.1 1.2 1.3 Flaherty, A. W. (2005). Frontotemporal and dopaminergic control of idea generation and creative drive. Journal of Comparative Neurology, 493(1), 147-153. https://dx.doi.org/10.1002%2Fcne.20768
- ↑ Jamison, K. R. (1989). Mood disorders and patterns of creativity in British writers and artists. Psychiatry, 52(2), 125-134. https://www.ncbi.nlm.nih.gov/pubmed/2734415/
- ↑ von Hecker, U., & Meiser, T. (2005). Defocused attention in depressed mood: evidence from source monitoring. Emotion, 5(4), 456. https://doi.org/10.1037/1528-3542.5.4.456
- ↑ Moncrieff, J., Cohen, D., & Mason, J. P. (2009). The subjective experience of taking antipsychotic medication: a content analysis of Internet data. Acta Psychiatrica Scandinavica, 120(2), 102-111. https://doi.org/10.1111/j.1600-0447.2009.01356.x
- ↑ 5.0 5.1 Szmulewicz, A., Samamé, C., Caravotta, P., Martino, D. J., Igoa, A., Hidalgo-Mazzei, D., ... & Strejilevich, S. A. (2016). Behavioral and emotional adverse events of drugs frequently used in the treatment of bipolar disorders: clinical and theoretical implications. International journal of bipolar disorders, 4(1), 6. https://dx.doi.org/10.1186%2Fs40345-016-0047-3
- ↑ Bolling, M. Y., & Kohlenberg, R. J. (2004). Reasons for quitting serotonin reuptake inhibitor therapy: paradoxical psychological side effects and patient satisfaction. Psychotherapy and psychosomatics, 73(6), 380-385. https://doi.org/10.1159/000080392